Examkin

Question

Difficulty: MediumNeoplastic Processes

A 54-year-old man presents to the otolaryngology clinic with a painless right-sided neck mass that he first noticed 2 months ago. He reports no dysphagia, hoarseness, weight loss, or night sweats. He is a lifelong non-smoker and consumes alcohol on rare occasions. His past medical history is unremarkable, and he takes no daily medications. Physical examination reveals a 3.5-cm, firm, mobile, non-tender lymph node in the right jugulodigastric region. Flexible laryngoscopy shows a small, irregular exophytic lesion on the right palatine tonsil. Biopsy of the tonsillar lesion confirms non-keratinizing squamous cell carcinoma. Subsequent immunohistochemical staining of the tumor tissue demonstrates strong, diffuse positivity for the p16 protein. Which of the following cellular mechanisms is most directly responsible for the immunohistochemical findings in this patient's neoplasm?

  1. Viral oncoprotein-mediated degradation of a cell cycle regulator leading to compensatory upregulation of a cyclin-dependent kinase inhibitorAnswer
  2. B
    Viral oncoprotein-mediated ubiquitination of a key tumor suppressor preventing normal apoptotic responses to DNA damage
  3. C
    Epigenetic hypermethylation of a tumor suppressor gene promoter resulting in the loss of G1/S phase cell cycle arrest
  4. D
    Somatic point mutation in a proto-oncogene causing constitutive activation of a receptor tyrosine kinase
  5. E
    Chromosomal translocation creating a fusion gene that functions as a chimeric transcription factor

Answer

Viral oncoprotein-mediated degradation of a cell cycle regulator leading to compensatory upregulation of a cyclin-dependent kinase inhibitor
The patient has an HPV-associated oropharyngeal squamous cell carcinoma, which typically presents in younger, non-smoking patients with neck masses and primary lesions in the tonsils or base of the tongue. High-risk HPV strains express the E7 oncoprotein, which binds and degrades the retinoblastoma (Rb) tumor suppressor protein (a cell cycle regulator). The functional loss of Rb releases the E2F transcription factor, promoting unregulated cellular progression from the G1 to the S phase. Normally, Rb exerts negative feedback on the production of p16, which is a cyclin-dependent kinase inhibitor (CDKN2A). When Rb is degraded by E7, this negative feedback is lost, leading to massive, compensatory cellular overproduction of p16 in a futile attempt to halt the cell cycle. Therefore, diffuse p16 positivity on immunohistochemistry serves as a strong surrogate marker for an HPV-driven neoplastic process.

Step-by-Step Solution

1
Analyze the clinical presentation and diagnostic findings.
The patient has oropharyngeal (tonsillar) squamous cell carcinoma. He is a non-smoker, and the tumor is strongly positive for p16.
Identifying the patient demographic and the specific immunohistochemical marker is necessary to determine the underlying etiology of the head and neck cancer.
2
Correlate the diagnostic findings with the specific neoplastic etiology.
p16 positivity in an oropharyngeal mass in a non-smoker is a highly sensitive and specific surrogate marker for infection with high-risk Human Papillomavirus (HPV), typically strains 16 or 18.
HPV-associated squamous cell carcinomas have distinct molecular profiles, prognoses, and pathophysiologic mechanisms compared to traditional smoking/alcohol-associated carcinomas.
3
Trace the foundational molecular mechanism of the identified etiology to the laboratory finding.
HPV produces the E7 oncoprotein, which binds and degrades the retinoblastoma (Rb) protein. The loss of Rb frees the E2F transcription factor. Because Rb normally suppresses p16 production via negative feedback, the loss of Rb leads to uninhibited, massive compensatory overexpression of the p16 protein.
The question asks for the direct cellular mechanism responsible for the specific immunohistochemical finding (p16 overexpression).

Key Concept

Molecular pathogenesis of HPV-associated squamous cell carcinoma and the basis for p16 overexpression.
Estimated Time:1m 30s
Rate this question

Topics

Neoplastic Processes

More questions from this topic